4Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
7Lee MH, Yang HI, Liu J, et,71. Prediction models of long- term cirrhosis and hepatocellular carcinoma risk in chronic hepa- titis B patients: risk scores integrating host and virus profiles [J]. Hepatology, 2013, 58 (2): 546-554.
8Lee HW, Lee HJ, Hwang JS, etal. Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B [J]. Hepatology, 2010, 51 (2): 415-421.
9Cai W, Xie Q, An B, etal. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to tel- bivudine in HBeAg-positive chronic hepatitis B patients [J]. J ClinVirol, 2010, 48 (1): 22-26.
